Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Secular Trends in the Pharmacologic Treatment of Osteoporosis and Malignancy-Related Bone Disease from 2009 to 2020

Journal of General Internal Medicine(2021)10.1007/s11606-021-06938-8Source: DataRank Database

Secular Trends in the Pharmacologic Treatment of Osteoporosis and Malignancy-Related Bone Disease from 2009 to 2020 is a research paper published in Journal of General Internal Medicine (2021). On theSindex it has a DataRank of 0. It has been cited 18 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access18 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.73)OA: bronzeTopics (40)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Kristin M. D’Silva ORCID,Elaine W Yu ORCID,Joan Landon,Rishi Desai ORCID,Seoyoung C. Kim ORCID

Live enrichment

PubMed:34100235 PMC:PMC9198174 OpenAlex:https://openalex.org/W3166368938

Foundation for the National Institutes of Health

Grant: T32DK007028

Foundation for the National Institutes of Health

Grant: T32AR007258

Rheumatology Research Foundation

Grant: Scientist Development Award

National Institutes of Health

Grant: 3T32DK007028-48S1

Training Program in Endocrinology

National Institutes of Health

Grant: 2T32AR007258-46

Research Training in Rheumatology at Massachusetts General Hospital

FWCI

0.73

Citation Percentile

0.7%

Citation Trend

2021

2022

2023

2024

2025

2026

bronzeLicense: Springer TDM

journalhttps://link.springer.com/content/pdf/10.1007/s11606-021-06938-8.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s11606-021-06938-8.pdf

publisherhttps://link.springer.com/article/10.1007/s11606-021-06938-8/fulltext.html

journalhttps://doi.org/10.1007/s11606-021-06938-8

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34100235

Fields of Study

Bone health and treatmentsBone health and osteoporosis researchBone Metabolism and Diseases03 medical and health sciences0302 clinical medicine

MeSH Terms

DenosumabZoledronic AcidAgedFemaleHumansMaleMiddle AgedOsteoporosisCohort StudiesOsteoporosis, PostmenopausalAlendronateBone Density Conservation AgentsOsteoporotic Fractures

Keywords

MedicineDenosumabOsteoporosisZoledronic acidCohortMedical prescriptionBisphosphonateInternal medicinePediatricsFractureBisphosphonatesPharmacoepidemiologyMaleAlendronateBone Density Conservation AgentsMiddle AgedCohort StudiesHumansFemaleOsteoporosis, PostmenopausalOsteoporotic FracturesAged

Sustainable Development Goals

SDG 3: 3. Good health

Secular Trends in the Pharmacologic Treatment of Osteoporosis and Malignancy-Related Bone Disease from 2009 to 2020

FAIR Checklist

Authors (6)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)